BA
RMTI icon

BKS Advisors’s Rockwell Medical RMTI Stock Holding History

BKS Advisors’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.28M Buy
2,048
+55
+3% +$25.1K 0.52% 55
2018
Q4 		$495K Sell
1,993
-235
-11% -$93.5K 0.22% 110
2018
Q3 		$1.03M Buy
2,228
+63
+3% +$30.5K 0.38% 71
2018
Q2 		$1.17M Sell
2,165
-9
-0.4% -$5.4K 0.42% 67
2018
Q1 		$1.25M Hold
2,174
– – 0.45% 61
2017
Q4 		$1.39M Sell
2,174
-7
-0.3% -$4.93K 0.5% 55
2017
Q3 		$2.05M Buy
2,181
+18
+0.8% +$13.8K 0.8% 43
2017
Q2 		$1.89M Hold
2,163
– – 0.77% 41
2017
Q1 		$1.49M Sell
2,163
-5
-0.2% -$3.29K 0.65% 48
2016
Q4 		$1.56M Sell
2,168
-73
-3% -$50.5K 0.73% 47
2016
Q3 		$1.65M Sell
2,241
-9
-0.4% -$7.29K 0.76% 44
2016
Q2 		$1.87M Sell
2,250
-45
-2% -$41.8K 0.96% 36
2016
Q1 		$1.9M Sell
2,295
-18
-0.8% -$14.1K 0.99% 30
2015
Q4 		$2.6M Sell
2,313
-3
-0.1% -$3.49K 1.34% 21
2015
Q3 		$1.96M Buy
2,316
+27
+1% +$39.1K 1.09% 31
2015
Q2 		$4.06M Sell
2,289
-23
-1% -$29.2K 1.94% 15
2015
Q1 		$2.78M Buy
+2,312
New +$2.71M 1.32% 23

Other funds holding RMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BKS Advisors's RMTI Position: Q1 2019 in Review

BKS Advisors increased its Rockwell Medical (RMTI) stake by 2.8% in Q1 2019, buying an estimated $25.1K and bringing the position to 2,048 shares worth $1.28M. The position accounts for 0.52% of the portfolio, ranked #55.

BKS Advisors first reported a position in RMTI in Q1 2015 and has held it in 17 quarters since. The position peaked at $4.06M in Q2 2015. 84 funds tracked by Wall St. Rank hold RMTI as of Q1 2019.

  • BKS Advisors held 2,048 shares of Rockwell Medical worth $1.28M as of Q1 2019.
  • BKS Advisors bought 55 Rockwell Medical shares in Q1 2019, an estimated $25.1K.
  • Rockwell Medical made up 0.52% of BKS Advisors's portfolio in Q1 2019, its #55 holding.
  • BKS Advisors first reported a position in Rockwell Medical in Q1 2015 and has held it in 17 quarters since.
  • BKS Advisors's Rockwell Medical position peaked at $4.06M in Q2 2015.
  • 84 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2019.

Based on BKS Advisors's 13F filing for Q1 2019, filed 16 Apr 2019.